期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

硫唑嘌呤治疗晚发型重症肌无力的疗效 被引量：2

下载PDF
导出
摘要 重症肌无力（myasthenia gravis）是一种获得性自身免疫性疾病,一般认为发病年龄有2个高峰,分为早发型和晚发型。但近年临床资料显示,晚发型重症肌无力（late-onset myasthenia gravis,LOMG）的发病呈增高趋势。
作者 李平 李双英 张巧莲
机构地区 武警后勤学院附属医院
出处 《实用医学杂志》 CAS 北大核心 2016年第10期1725-1726,共2页 The Journal of Practical Medicine
关键词 重症肌无力 晚发型 MYASTHENIA GRAVIS 硫唑嘌呤 自身免疫性疾病 发病年龄 新斯的明试验 四肢肌肉 糖皮质激素
分类号 R746.1 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献10

  • 1ZIVKOVIC SA, CLEMENS PR. Char- acteristics of late-onset myasthenia gravis [J]. J Neurol, 2012,259(10): 2167-2171.
  • 2CHUANG WY, STRBEL P, BOHLE- NDER-WILLKE AL, et al. Late-onset myasthenia gravis-CTLA4 (low) geno- type association and low-for-age thymic output of nave T ceils [J]. J Autoim- mun, 2014,52:122-129.
  • 3SIVAKUMAR S. Current and emergingtreatments for the management of myas- thenia avis [J]. Ther Clin Risk Man- ag, 2011,7:313-323.
  • 4张丽丽,赵欣欣,杨琦,闵睿,王宗谦.糖皮质激素对内毒素耐受的影响[J].实用药物与临床,2014,17(6):724-727. 被引量：2
  • 5王勇,应秀娟.小剂量糖皮质激素布地奈德吸入在支气管哮喘治疗中的应用[J].实用药物与临床,2014,17(2):199-202. 被引量：54
  • 6高晨,黄佳.北京等四城市2012年儿科糖皮质激素门诊处方合理用药抽样分析与比较[J].实用药物与临床,2014,17(9):1214-1218. 被引量：11
  • 7SIEB JP. Myasthenia gravis: An update for the clinician [J]. Clin Exp Immunol,2014,175(3) :408-418.
  • 8YI JS, DECROOS EC, SERS DB, et al. Prolonge-eell depletion in MuSK myasthenia gravis following rituximab treatment [J]. Muscle Nerve, 2013,48 (6) :992-993.
  • 9JACK KL. A review of azathioprine-in- duced hepatotoxicity and myelosuppres- sion in myasthenia gravis [J]. Muscle Nerve, 2014,50(4) :719.
  • 10WOLFE GI, SILVESTRI NJ. Treat- ment-refractory myasthenia gravis [J]. J Clin Neuromuseul Dis, 2014,15 (4) : 167-178.

二级参考文献37

  • 1Rearte B,Landoni V,Laborde E,et al.Differential effects of glucocorticoids in the establishment and maintenance of endotoxin tolerance[J].Clin Exp Immunol,2010,159:208-216.
  • 2Kristofor KE,Shigeki T,Farshid N,et al.Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cell[J].J Immunol,2009,183:298-309.
  • 3Olivier J,Sandrine R,Natacha B,et al.Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo[J].Immunology,2008,126:35-44.
  • 4Glenn F,Evans,Zuckerman SH,et al.Glucocorticoid-dependent and independent mechanisms involved in lipopolysaccharide tolerance[J].Eur J Immunol,1991;21:1973-1979.
  • 5Cabezon R,Ricart E,Espana C,et al.Gram-negative enterobacteria induce tolerogenic maturation in dexamethasone conditioned dendritic cells[J].PLoS One,2012,7:e52456.
  • 6Randow F,Syrbe U,Meisel C,et al.Mechanism of endotoxin desen-sitization:involvement of interleukin 10 and transforming growth factor beta[J].J Exp Med,1995,181:1887-1892.
  • 7Fang Z,Bogoljub C,Hongmei Li,et al.IL-10 deficiency blocks the ability of LPS to regulate expression of tolerance-related molecules on dendritic cells[J].Eur J Immuno,2012,42:1449-1458.
  • 8Berg DJ,Kuhn R,Rajewsky K,et al.Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance[J].J Clin Invest,1995,96:2339-2347.
  • 9Annane D,Bellissant E,Bollaert PE,et al.Corticosteroids in the treatment of severe sepsis and septic shock in adults:a systematic review[J].JAMA,2009,301:2362-2375.
  • 10Niimi A,Matsumoto H,Mishima M. Eosinophilic airway disorders associated with chronic cough[J].{H}PULMONARY PHARMACOLOGY & THERAPEUTICS,2009,(02):114-120.

共引文献64

同被引文献7

引证文献2

实用医学杂志
2016年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部